INTRODUCTION
B ranchretinalveinocclusion(BRVO)isthesecondmost commonmajorretinalvasculardiseaseafterdiabetic retinopathy [1] .TheprevalenceofBRVOhasbeenestimatedto rangefrom0.6%to1.1% [2] [3] [4] .Themajorriskfactorsfor BRVOincludeincreasingage,hypertension,andconcomitant cardiovasculardiseases [5] [6] .ThepathogenesisofBRVOis believedtoinvolvebothretinalveincompression, byan adjacentatheroscleroticartery,aswellasdamagetothe vesselwallthroughthe trophicchangesofvenous endotheliumaswellasintimaormediapossiblyresultingin thrombusformation [7] .BRVOmaybeasymptomaticor associatedwithblurringinthevisualfieldcorrespondingto theinvolvedretinalquadrant.Commonvision-threatening complicationsarecystoidmacularedema,macularischemia andvitreoushemorrhage [8] [9] .Macularedemaisthemost commoncauseofvisuallossinthesepatients,andintravitreal injectionofanti-vascularendothelialgrowthfactor(anti-VEGF)agentsisoneofthegenerallyacceptedandoftenused treatmentoptions.Ithasbeensuggestedthattheclinical courseofretinalveinocclusionmaybeaffectedbytheextent ofretinalischemia,includingischemiaoccurringinthe periphery [10] . Fluoresceinangiography(FA)isabletodeterminewhether thevisionlossisduetomacularedemaorischemia [2] .Onthe otherhand,FAcanalsobeanimportanttooltodetect peripheralischemia.However,imagingoftheperipheral retinabycommonmethodsofFAisnotoptimalandoften accompaniedbydifficultiestodepictperipheral pathophysiologicalretinalalterations.Thismaybeduetothe fieldofviewofthetraditionalfunduscameras,whichis varyingfrom30to60degrees;inaddition,imagesof differentareasarenottakenconcurrentlyandcomparisonis thereforenotprecise [11] [12] .Furthermore,withtraditionalfundus [15] . Therelationshipbetweenperipheralretinalischemia, elevatedVEGFlevelsandpersistentmacularedemaisnot fullyunderstood.Ithasbeensuggestedthattheclinical courseofretinalveinocclusionmaybeaffectedbytheextent ofretinalischemia,includingischemiaoccurringinthe periphery [10] . Sinceretinalischemiaisassociatedwithhigherlevelsof VEGF,detectingtheextentoftheretinalnon-perfusionis importantinpatientmanagement [16] .Littleisknownaboutthe [17] [18] .ByapplyingUWFA,weevaluatedthe associationbetweenthefrequencyandamountofintravitreal ranibizumabinjectionsandtheextentofnon-perfusedareas inpatientswithBRVOandmacularedemaintheperipheral retina.Toourknowledge,thisisthefirststudytoapplyan inventedgridforquantificationofnon-perfusedareasof UWFAinpatientswithBRVO.Inthisstudy,treatmentwith ranibizumabresultedinasignificantimprovementinBCVA andreductioninmeanCSTofthetreatedeyes.However, patientswithperipheralretinalnon-perfusionreceivedmore intravitrealinjectionsfortreatmentofthemacularedema. Inourstudy,baselineCSTwassignificantlylowerinpatients withoutperipheralretinalnon-perfusion.Similarfindings havebeenreportedbySinger [19] .Theyevaluated32 patientswithretinalveinocclusionandrefractorymacular edemaandfoundthatmeanCSTwashigherinpatientswith morenon-perfusedareas.Prasad [10] investigatedUWFA angiogramsfrom80eyesof78patientswithadiagnosisof BRVO(86%)orhemi-centralretinalveinocclusions (CRVOs)(14%).Untreatednon-perfusionatanylocation wasassociatedwithmacularedema.Theysuggestedthat areasofuntreatedretinalnon-perfusioncouldbethesource ofproductionofbiochemicalmediatorsthatpromote neovascularizationandmacularedema.Campochiaro [20] evaluatedatotalof392 (397) 
